SOLANA BEACH, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the ...
The "Stereotactic Neuro-Navigation System Market - A Global and Regional Analysis: Focus on Product, Application, End User, and Region - Analysis and Forecast, 2025-2035" report has been added to ...
SOLANA BEACH, Calif., Jan. 16, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain ...
DUBLIN--(BUSINESS WIRE)--The "Europe Stereotactic Neuro-Navigation System Market: Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering. The Europe stereotactic ...
SOLANA BEACH, CALIFORNIA / ACCESS Newswire / January 27, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise ...
Please provide your email address to receive an email when new articles are posted on . The SmartFrame OR system provides guidance of instruments or devices during surgery. The company plans a limited ...